All News

    Early Transfusions, Treatments May Improve Outcomes in Low-Risk MDS

    April 25th 2024, 7:00pm

    Article

    Receiving early transfusions and treatment to reduce transfusion dependency significantly improves survival and quality of life in low-risk MDS.

    The Long and Winding Road Leading to My Non-Hodgkin Lymphoma

    April 25th 2024, 5:00pm

    Article

    The day I found out I had cancer, my wife and I thought I would just be going in for a scan.

    Aspirin Linked to Lower Metastasis in Esophageal, Colorectal Cancers

    April 25th 2024, 3:00pm

    Article

    Research has shown aspirin use to be associated with lower rates of metastasis for some patients.

    Meaghan Mooney, B.S.N., RN, OCN, Wins CURE’s 2024 Extraordinary Healer® Award

    April 25th 2024, 1:00pm

    Article

    During this in-person event, over 500 attendees celebrated the remarkable efforts made by oncology nurses in the care of patients with cancer.

    Nurse Suggests Questions to Ask Before Carvykti Treatment for Myeloma

    April 24th 2024, 9:00pm

    Video

    With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers before treatment, a nurse said.

    Carvykti Provides Good Long-Term Quality of Life in Pretreated Myeloma

    April 24th 2024, 7:00pm

    Article

    Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.

    Receiving Chemotherapy for Colon Cancer on My Birthday

    April 24th 2024, 5:00pm

    Article

    At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying cancer-free.

    Attitudes With Latitude About My Cancer

    April 24th 2024, 3:00pm

    Article

    Even though I lost my hair from cancer treatment, I didn't let that stop me from styling my hair with attitude.

    Enhertu Marks First Therapy Approved Across HER2-Positive Solid Tumors

    April 24th 2024, 1:00pm

    Article

    Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

    Tecentriq, Cabometyx May Not Improve Survival Over Chemo in NSCLC

    April 23rd 2024, 9:00pm

    Article

    Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.